Skip to main content
Search
Search
Quick Search anywhere
Quick Search in Journals
Quick Search in Journals
Quick Search in Journals
Quick Search in Journals
Quick Search in Journals
Quick Search in Journals
Quick Search in Journals
Quick Search in Journals
Quick Search in Journals
Quick Search in Journals
Skip main navigation
JACC Journals › JACC › Archives › Vol. 76 No. 18
Previous
Next

Venous Thromboembolism Associated With Pregnancy: JACC Focus SeminarOpen Access

JACC Focus Seminar

JACC. 2020 Nov, 76 (18) 2128–2141
Sections

Central Illustration

Abstract

Venous thromboembolism (VTE), composed of pulmonary embolism and deep venous thrombosis, is a significant cause of maternal mortality in the developed world. Normal physiological changes of pregnancy increase coagulability, which is compounded by patient-inherited and acquired risk factors. Depending on these risks and peripartum stage, the benefits of thromboprophylaxis can outweigh potential side effects. Diagnosis requires cautious clinical acumen because many symptoms of normal pregnancy mimic those of VTE and algorithmic tools used in the nonpregnant population are not equally applicable. Choice of imaging technique must account for potential risk to the fetus and altered test accuracy (sensitivity and specificity) in the setting of pregnancy. When VTE is diagnosed, anticoagulation is the backbone of treatment, with more advanced therapies being options for those with right ventricular dysfunction or unstable hemodynamics. Overall, pregnancy-associated VTE is complex, and management decisions should be individualized and informed by patient preferences.

Highlights

•

Prevention and management of venous thromboembolism (VTE) associated with pregnancy must consider outcomes of both mother and fetus.

•

Treatment decisions should account for baseline and pregnancy-specific clinical factors and patient preferences.

•

Randomized studies are necessary to identify safe, effective strategies for prevention and treatment of pregnancy-associated VTE.

References

  • 1. Konstantinides S.V., Meyer G., Becattini C., et al. "2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)". Eur Heart J 2020;41:543-603.

    CrossrefMedlineGoogle Scholar

  • 2. "Pregnancy Mortality Surveillance System". Center for Disease Control and Prevention, 2019. Available at: https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm. Accessed October 2, 2020.

    Google Scholar

  • 3. Creanga A.A., Syverson C., Seed K., Callaghan W.M. "Pregnancy-related mortality in the United States, 2011-2013". Obstet Gynecol 2017;130:366-373.

    CrossrefMedlineGoogle Scholar

  • 4. Parunov L.A., Soshitova N.P., Ovanesov M.V., Panteleev M.A., Serebriyskiy "Epidemiology of venous thromboembolism (VTE) associated with pregnancy". Birth Defects Res C Embryo Today 2015;105:167-184.

    CrossrefMedlineGoogle Scholar

  • 5. Marik P.E., Plante L.A. "Venous thromboembolic disease and pregnancy". N Engl J Med 2008;359:2025-2033.

    CrossrefMedlineGoogle Scholar

  • 6. Franchini M. "Haemostasis and pregnancy". Thromb Haemost 2006;95:401-413.

    CrossrefMedlineGoogle Scholar

  • 7. Brenner B. "Haemostatic changes in pregnancy". Thromb Res 2004;114:409-414.

    CrossrefMedlineGoogle Scholar

  • 8. Jacobsen A.F., Qvigstad E., Sandset P.M. "Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy". BJOG 2003;110:139-144.

    CrossrefMedlineGoogle Scholar

  • 9. Kujovich J.L. "Hormones and pregnancy: thromboembolic risks for women". Br J Haematol 2004;126:443-454.

    CrossrefMedlineGoogle Scholar

  • 10. Eichinger S. "D-dimer testing in pregnancy". Semin Vasc Med 2005;5:375-378.

    CrossrefMedlineGoogle Scholar

  • 11. Di Prima F.A., Valenti O., Hyseni E., et al. "Antiphospholipid Syndrome during pregnancy: the state of the art". J Prenat Med 2011;5:41-53.

    MedlineGoogle Scholar

  • 12. Macklon N.S., Greer I.A., Bowman A.W. "An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy". Br J Obstet Gynaecol 1997;104:191-197.

    CrossrefMedlineGoogle Scholar

  • 13. James A.H., Tapson V.F., Goldhaber S.Z. "Thrombosis during pregnancy and the postpartum period". Am J Obstet Gynecol 2005;193:216-219.

    CrossrefMedlineGoogle Scholar

  • 14. Jacobsen A.F., Drolsum A., Klow N.E., Dahl G.F., Qvigstad E., Sandset P.M. "Deep vein thrombosis after elective cesarean section". Thromb Res 2004;113:283-288.

    CrossrefMedlineGoogle Scholar

  • 15. Bechtel J.J., Mountford M.C., Ellinwood W.E. "Massive pulmonary embolism in pregnancy treated with catheter fragmentation and local thrombolysis". Obstet Gynecol 2005;106:1158-1160.

    CrossrefMedlineGoogle Scholar

  • 16. Lindqvist P., Dahlback B., Marsal K. "Thrombotic risk during pregnancy: a population study". Obstet Gynecol 1999;94:595-599.

    MedlineGoogle Scholar

  • 17. Calhoun B., Hoover E., Seybold D., et al. "Outcomes in an obstetrical population with hereditary thrombophilia and high tobacco use". J Matern Fetal Neonatal Med 2018;31:1267-1271.

    CrossrefMedlineGoogle Scholar

  • 18. Devis P., Knuttinen M.G. "Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management". Cardiovasc Diagn Ther 2017;7:S309-S319.

    CrossrefMedlineGoogle Scholar

  • 19. Pomp E.R., Lenselink A.M., Rosendaal F.R., Doggen C.J. "Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study". J Thromb Haemost 2008;6:632-637.

    CrossrefMedlineGoogle Scholar

  • 20. Sultan A.A., West J., Tata L.J., Fleming K.M., Nelson-Piercy C., Grainge M.J. "Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study". Br J Haematol 2012;156:366-373.

    CrossrefMedlineGoogle Scholar

  • 21. Petersen J.F., Bergholt T., Nielsen A.K., Paidas M.J., Lokkegaard E.C. "Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy. Danish nationwide historical cohort 1995-2009". Thromb Haemost 2014;112:73-78.

    CrossrefMedlineGoogle Scholar

  • 22. Liu N., Vigod S.N., Farrugia M.M., Urquia M.L., Ray J.G. "Venous thromboembolism after induced abortion: a population-based, propensity-score-matched cohort study in Canada". Lancet Haematol 2018;5:e279-e288.

    CrossrefMedlineGoogle Scholar

  • 23. Rodger M. "Pregnancy and venous thromboembolism: 'TIPPS' for risk stratification". Hematol Am Soc Hematol Educ Program 2014;2014:387-392.

    CrossrefMedlineGoogle Scholar

  • 24. Lamorte W.W. "Measures of Association: Risk Ratios and Rate Ratios (Relative Risk)". Boston, MA: Boston University School of Public Health, 2018.

    Google Scholar

  • 25. Villani M., Dentali F., Colaizzo D., et al. "Pregnancy-related venous thrombosis: comparison between spontaneous and ART conception in an Italian cohort". BMJ Open 2015;5:e008213.

    CrossrefMedlineGoogle Scholar

  • 26. "ACOG Practice Bulletin No. 196: Thromboembolism in pregnancy". Obstet Gynecol 2018;132:e1-e17.

    CrossrefMedlineGoogle Scholar

  • 27. Bates S.M., Middeldorp S., Rodger M., James A.H., Greer I. "Guidance for the treatment and prevention of obstetric-associated venous thromboembolism". J Thromb Thrombolysis 2016;41:92-128.

    CrossrefMedlineGoogle Scholar

  • 28. Liu S., Rouleau J., Joseph K.S., et al. "Epidemiology of pregnancy-associated venous thromboembolism: a population-based study in Canada". J Obstet Gynaecol Can 2009;31:611-620.

    CrossrefMedlineGoogle Scholar

  • 29. Bezemer I.D., van der Meer F.J., Eikenboom J.C., Rosendaal F.R., Doggen C.J. "The value of family history as a risk indicator for venous thrombosis". Arch Intern Med 2009;169:610-615.

    CrossrefMedlineGoogle Scholar

  • 30. Robertson L., Wu O., Langhorne P., et al. "Thrombophilia in pregnancy: a systematic review". Br J Haematol 2006;132:171-196.

    CrossrefMedlineGoogle Scholar

  • 31. Gerhardt A., Scharf R.E., Greer I.A., Zotz R.B. "Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium". Blood 2016;128:2343-2349.

    CrossrefMedlineGoogle Scholar

  • 32. Gerhardt A., Scharf R.E., Beckmann M.W., et al. "Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium". N Engl J Med 2000;342:374-380.

    CrossrefMedlineGoogle Scholar

  • 33. Robertson L., Wu O., Langhorne P., et al. "Thrombosis risk and economic assessment of thrombophilia screening (TREATS) study. Thrombophilia in pregnancy: a systematic review". Br J Haematol 2005;132:171-196.

    CrossrefGoogle Scholar

  • 34. Lima F., Khamashta M.A., Buchanan N.M., Kerslake S., Hunt B.J., Hughes G.R. "A study of sixty pregnancies in patients with the antiphospholipid syndrome". Clin Exp Rheumatol 1996;14:131-136.

    MedlineGoogle Scholar

  • 35. Branch D.W., Silver R.M., Blackwell J.L., Reading J.C., Scott J.R. "Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience". Obstet Gynecol 1992;80:614-620.

    MedlineGoogle Scholar

  • 36. Branch D.W., Holmgren C., Goldberg J.D. "Committee on Practice Bulletins-Obstetrics Practice Bulletin no 132: antiphospholipid antibody syndrome". Obstet Gynaecol 2012;120:1514-1521.

    CrossrefGoogle Scholar

  • 37. Sennstrom M., Rova K., Hellgren M., et al. "Thromboembolism and in vitro fertilization - a systematic review". Acta Obstet Gynecol Scand 2017;96:1045-1052.

    CrossrefMedlineGoogle Scholar

  • 38. Chan W.S. "The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology". Curr Opin Obstet Gynecol 2009;21:207-218.

    CrossrefMedlineGoogle Scholar

  • 39. Rova K., Passmark H., Lindqvist P.G. "Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles". Fertil Steril 2012;97:95-100.

    CrossrefMedlineGoogle Scholar

  • 40. Rodger M.A., Hague W.M., Kingdom J., et al. "Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial". Lancet 2014;384:1673-1683.

    CrossrefMedlineGoogle Scholar

  • 41. Douketis J.D., Ginsberg J.S., Burrows R.F., Duku E.K., Webber C.E., Brill-Edwards P. "The effects of long-term heparin therapy during pregnancy on bone density. A prospective matched cohort study". Thromb Haemost 1996;75:254-257.

    CrossrefMedlineGoogle Scholar

  • 42. Dahlman T.C. "Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin". Am J Obstet Gynecol 1993;168:1265-1270.

    CrossrefMedlineGoogle Scholar

  • 43. Rodger M.A., Gris J.C., de Vries JIP , et al. "Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials". Lancet 2016;388:2629-2641.

    CrossrefMedlineGoogle Scholar

  • 44. Van Driel D., Wesseling J., Sauer P.J., van Der Veer E., Touwen B.C., Smrkovsky M. "In utero exposure to coumarins and cognition at 8 to 14 years old". Pediatrics 2001;107:123-129.

    CrossrefMedlineGoogle Scholar

  • 45. Hall J.G., Pauli R.M., Wilson K.M. "Maternal and fetal sequelae of anticoagulation during pregnancy". Am J Med 1980;68:122-140.

    CrossrefMedlineGoogle Scholar

  • 46. Schaefer C., Hannemann D., Meister R., et al. "Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study". Thromb Haemost 2006;95:949-957.

    CrossrefMedlineGoogle Scholar

  • 47. Bapat P., Pinto L.S., Lubetsky A., et al. "Examining the transplacental passage of apixaban using the dually perfused human placenta". J Thromb Haemost 2016;14:1436-1441.

    CrossrefMedlineGoogle Scholar

  • 48. Yarrington C.D., Valente A.M., Economy K.E. "Cardiovascular management in pregnancy: antithrombotic agents and antiplatelet agents". Circulation 2015;132:1354-1364.

    CrossrefMedlineGoogle Scholar

  • 49. Sessa M., Mascolo A., Callreus T., Capuano A., Rossi F., Andersen M. "Direct-acting oral anticoagulants (doacs) in pregnancy: new insight from vigibase((R))". Sci Rep 2019;9:7236.

    CrossrefMedlineGoogle Scholar

  • 50. Dempfle C.E. "Minor transplacental passage of fondaparinux in vivo". N Engl J Med 2004;350:1914-1915.

    CrossrefMedlineGoogle Scholar

  • 51. Cohen H., Arachchillage D.R., Middeldorp S., Beyer-Westendorf J., Abdul-Kadir R. "Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH: reply". J Thromb Haemost 2017;15:195-197.

    CrossrefMedlineGoogle Scholar

  • 52. Gould M.K., Dembitzer A.D., Doyle R.L., Hastie T.J., Garber A.M. "Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials". Ann Intern Med 1999;130:800-809.

    CrossrefMedlineGoogle Scholar

  • 53. Quinlan D.J., Mcquillan A., Eikelboom J.W. "Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials". Ann Intern Med 2004;140:175-183.

    CrossrefMedlineGoogle Scholar

  • 54. Galambosi P., Hiilesmaa V., Ulander V.M., Laitinen L., Tiitinen A., Kaaja R. "Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density". Thromb Res 2016;143:122-126.

    CrossrefMedlineGoogle Scholar

  • 55. Lim W., Dentali F., Eikelboom J.W., Crowther M.A. "Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency". Ann Intern Med 2006;144:673-684.

    CrossrefMedlineGoogle Scholar

  • 56. Warkentin T.E., Levine M.N., Hirsh J., et al. "Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin". N Engl J Med 1995;332:1330-1335.

    CrossrefMedlineGoogle Scholar

  • 57. Barbour L.A., Smith J.M., Marlar R.A. "Heparin levels to guide thromboembolism prophylaxis during pregnancy". Am J Obstet Gynecol 1995;173:1869-1873.

    CrossrefMedlineGoogle Scholar

  • 58. Stephenson M.L., Serra A.E., Neeper J.M., Caballero D.C., Mcnulty J. "A randomized controlled trial of differing doses of postcesarean enoxaparin thromboprophylaxis in obese women". J Perinatol 2016;36:95-99.

    CrossrefMedlineGoogle Scholar

  • 59. Knol H.M., Schultinge L., Veeger N.J., Kluin-Nelemans H.C., Erwich J.J., Meijer K. "The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy". Thromb Res 2012;130:334-338.

    CrossrefMedlineGoogle Scholar

  • 60. Roshani S., Cohn D.M., Stehouwer A.C., et al. "Incidence of postpartum haemorrhage in women receiving therapeutic doses of low-molecular-weight heparin: results of a retrospective cohort study". BMJ Open 2011;1:e000257.

    CrossrefMedlineGoogle Scholar

  • 61. Mitic G.K.M., Radovic P., Novakov-Mikic A. "Therapeutic versus prophylactic low molecular weight heparin during pregnancy: the incidence of treatment complicaitons (abstr)". Thromb Res 2011;127.

    CrossrefGoogle Scholar

  • 62. Rodger M.A., Phillips P., Kahn S.R., et al. "Low molecular weight heparin to prevent postpartum venous thromboembolism: a pilot study to assess the feasibility of a randomized, open-label trial". Thromb Res 2016;142:17-20.

    CrossrefMedlineGoogle Scholar

  • 63. Bates S.M., Greer I.A., Middeldorp S., Veenstra D.L., Prabulos A.M., Vandvik P.O. "VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines". Chest 2012;141:e691s-e736s.

    CrossrefMedlineGoogle Scholar

  • 64. Wood S.C.S., Ross S. "Does induction of labour increase the risk of caesarean section? A systematic review and meta-analysis of trials in women with intact membranes". BJOG 2014;121:674-685.

    CrossrefMedlineGoogle Scholar

  • 65. Danilack V.A., Dore D.D., Triche E.W., Muri J.H., Phipps M.G., Savitz D.A. "The effect of labour induction on the risk of caesarean delivery: using propensity scores to control confounding by indication". BJOG 2016;123:1521-1529.

    CrossrefMedlineGoogle Scholar

  • 66. Leffert L.R., Dubois H.M., Butwick A.J., Carvalho B., Houle T.T., Landau R. "Neuraxial anesthesia in obstetric patients receiving thromboprophylaxis with unfractionated or low-molecular-weight heparin: a systematic review of spinal epidural hematoma". Anesth Analg 2017;125:223-231.

    CrossrefMedlineGoogle Scholar

  • 67. Leduc D., Senikas V., Lalonde A.B., Clinical Practice Obstetrics C. "Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage". J Obstet Gynaecol Can 2009;31:980-993.

    CrossrefMedlineGoogle Scholar

  • 68. Chan W.S., Rey E., Kent N.E., et al. "Venous thromboembolism and antithrombotic therapy in pregnancy". J Obstet Gynaecol Can 2014;36:527-553.

    CrossrefMedlineGoogle Scholar

  • 69. Kamel H., Navi B.B., Sriram N., Hovsepian D.A., Devereux R.B., Elkind M.S. "Risk of a thrombotic event after the 6-week postpartum period". N Engl J Med 2014;370:1307-1315.

    CrossrefMedlineGoogle Scholar

  • 70. Nordic Federation of Societies of Obstetrics and Gynecology. "Clinical Guideline of Thromboprophylaxis in IVF". 2015. Available at: https://nfog.org/about-us/guidelines/. Accessed October 2, 2020.

    Google Scholar

  • 71. Sultan A.A., West J., Grainge M.J., et al. "Development and validation of risk prediction model for venous thromboembolism in postpartum women: multinational cohort study". BMJ 2016;355:i6253.

    CrossrefMedlineGoogle Scholar

  • 72. Dargaud Y., Rugeri L., Fleury C., et al. "Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study". J Thromb Haemost 2017;15:897-906.

    CrossrefMedlineGoogle Scholar

  • 73. Dargaud Y., Rugeri L., Vergnes M.C., et al. "A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study". Br J Haematol 2009;145:825-835.

    CrossrefMedlineGoogle Scholar

  • 74. Lindqvist P.G., Torsson J., Almqvist A., Bjorgell O. "Postpartum thromboembolism: severe events might be preventable using a new risk score model". Vasc Health Risk Manag 2008;4:1081-1087.

    CrossrefMedlineGoogle Scholar

  • 75. Pabinger I., Grafenhofer H., Kaider A., et al. "Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis". J Thromb Haemost 2005;3:949-954.

    CrossrefMedlineGoogle Scholar

  • 76. White R.H., Chan W.S., Zhou H., Ginsberg J.S. "Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism". Thromb Haemost 2008;100:246-252.

    CrossrefMedlineGoogle Scholar

  • 77. De Stefano V., Martinelli I., Rossi E., et al. "The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis". Br J Haematol 2006;135:386-391.

    CrossrefMedlineGoogle Scholar

  • 78. Hull R.D., Pineo G.F., Stein P.D., et al. "Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review". Ann Intern Med 2001;135:858-869.

    CrossrefMedlineGoogle Scholar

  • 79. Bates S.M., Greer I.A., Pabinger I., Sofaer S., Hirsh J. "Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)". Chest 2008;133:844S-886S.

    CrossrefMedlineGoogle Scholar

  • 80. Bates S.M., Rajasekhar A., Middeldorp S., et al. "American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy". Blood Adv 2018;2:3317-3359.

    CrossrefMedlineGoogle Scholar

  • 81. Locht H., Lindstrom F.D. "Severe skin necrosis following warfarin therapy in a patient with protein C deficiency". J Intern Med 1993;233:287-289.

    CrossrefMedlineGoogle Scholar

  • 82. Berkompas D.C. "Coumadin skin necrosis in a patient with a free protein S deficiency: case report and literature review". Indiana Med 1991;84:788-791.

    MedlineGoogle Scholar

  • 83. Broekmans A.W., Bertina R.M., Loeliger E.A., Hofmann V., Klingemann H.G. "Protein C and the development of skin necrosis during anticoagulant therapy". Thromb Haemost 1983;49:251.

    CrossrefMedlineGoogle Scholar

  • 84. Dentali F., Grandone E., Rezoagli E., Ageno W. "Efficacy of low molecular weight heparin in patients undergoing in vitro fertilization or intracytoplasmic sperm injection". J Thromb Haemost 2011;9:2503-2506.

    CrossrefMedlineGoogle Scholar

  • 85. Dentali F., Ageno W., Rezoagli E., et al. "Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature". J Thromb Haemost 2012;10:2075-2085.

    CrossrefMedlineGoogle Scholar

  • 86. Siristatidis C.S., Basios G., Pergialiotis V., Vogiatzi P. "Aspirin for in vitro fertilisation". Cochrane Database Syst Rev 2016;11:CD004832.

    MedlineGoogle Scholar

  • 87. Akhtar M.A., Sur S., Raine-Fenning N., et al. "Heparin for assisted reproduction: summary of a Cochrane review". Fertil Steril 2015;103:33-34.

    CrossrefMedlineGoogle Scholar

  • 88. Lindqvist P.G., Bremme K., Hellgren M. "Working Group on Hemostatic Disorders, Swedish Society of Obstetrics and Gynecology. Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism". Acta Obstet Gynecol Scand 2011;90:648-653.

    CrossrefMedlineGoogle Scholar

  • 89. Ricci G., Bogatti P., Fischer-Tamaro L., et al. "Factor V Leiden and prothrombin gene G20210A mutation and in vitro fertilization: prospective cohort study". Hum Reprod 2011;26:3068-3077.

    CrossrefMedlineGoogle Scholar

  • 90. Hendriksen J.M., Geersing G.J., Lucassen W.A., et al. "Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care". BMJ 2015;351:h4438.

    CrossrefMedlineGoogle Scholar

  • 91. Wells P.S., Anderson D.R., Rodger M., et al. "Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the simplired D-dimer". Thromb Haemost 2000;83:416-420.

    CrossrefMedlineGoogle Scholar

  • 92. Klok F.A., Mos I.C., Nijkeuter M., et al. "Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism". Arch Intern Med 2008;168:2131-2136.

    CrossrefMedlineGoogle Scholar

  • 93. Van Belle A., Buller H.R., Huisman M.V., et al. "Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography". JAMA 2006;295:172-179.

    CrossrefMedlineGoogle Scholar

  • 94. Quiroz R., Kucher N., Zou K.H., et al. "Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review". JAMA 2005;293:2012-2017.

    CrossrefMedlineGoogle Scholar

  • 95. Chan W.S., Chunilal S., Lee A., Crowther M., Rodger M., Ginsberg J.S. "A red blood cell agglutination D-dimer test to exclude deep venous thrombosis in pregnancy". Ann Intern Med 2007;147:165-170.

    CrossrefMedlineGoogle Scholar

  • 96. Chabloz P., Reber G., Boehlen F., Hohlfeld P., de Moerloose P. "TAFI antigen and D-dimer levels during normal pregnancy and at delivery". Br J Haematol 2001;115:150-152.

    CrossrefMedlineGoogle Scholar

  • 97. Van der Pol L.M., Tromeur C., Bistervels I.M., et al. "Pregnancy-adapted YEARS algorithm for diagnosis of suspected pulmonary embolism". N Engl J Med 2019;380:1139-1149.

    CrossrefMedlineGoogle Scholar

  • 98. Chan W.S., Spencer F.A., Ginsberg J.S. "Anatomic distribution of deep vein thrombosis in pregnancy". CMAJ 2010;182:657-660.

    CrossrefMedlineGoogle Scholar

  • 99. Chan W.S., Spencer F.A., Lee A.Y., et al. "Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging". CMAJ 2013;185:E194-E200.

    CrossrefMedlineGoogle Scholar

  • 100. Torkzad M.R., Bremme K., Hellgren M., et al. "Magnetic resonance imaging and ultrasonography in diagnosis of pelvic vein thrombosis during pregnancy". Thromb Res 2010;126:107-112.

    CrossrefMedlineGoogle Scholar

  • 101. Committee on Obstetric P. "Committee Opinion No. 723: guidelines for diagnostic imaging during pregnancy and lactation". Obstet Gynecol 2017;130:e210-e216.

    CrossrefMedlineGoogle Scholar

  • 102. Astani S.A., Davis L.C., Harkness B.A., Supanich M.P., Dalal I. "Detection of pulmonary embolism during pregnancy: comparing radiation doses of CTPA and pulmonary scintigraphy". Nucl Med Commun 2014;35:704-711.

    CrossrefMedlineGoogle Scholar

  • 103. Mitchell D.P., Rowan M., Loughman E., Ridge C.A., Macmahon P.J. "Contrast monitoring techniques in CT pulmonary angiography: an important and underappreciated contributor to breast dose". Eur J Radiol 2017;86:184-189.

    CrossrefMedlineGoogle Scholar

  • 104. Burton K.R., Park A.L., Fralick M., Ray J.G. "Risk of early-onset breast cancer among women exposed to thoracic computed tomography in pregnancy or early postpartum". J Thromb Haemost 2018;16:876-885.

    CrossrefMedlineGoogle Scholar

  • 105. Perisinakis K., Seimenis I., Tzedakis A., Damilakis J. "Perfusion scintigraphy versus 256-slice CT angiography in pregnant patients suspected of pulmonary embolism: comparison of radiation risks". J Nucl Med 2014;55:1273-1280.

    CrossrefMedlineGoogle Scholar

  • 106. Ntusi N.A., Samuels P., Moosa S., Mocumbi A.O. "Diagnosing cardiac disease during pregnancy: imaging modalities". Cardiovasc J Afr 2016;27:95-103.

    CrossrefMedlineGoogle Scholar

  • 107. Van Mens T.E., Scheres L.J., de Jong P.G., Leeflang M.M., Nijkeuter M., Middeldorp S. "Imaging for the exclusion of pulmonary embolism in pregnancy". Cochrane Database Syst Rev 2017;1:CD011053.

    MedlineGoogle Scholar

  • 108. Sostman H.D., Stein P.D., Gottschalk A., Matta F., Hull R., Goodman L. "Acute pulmonary embolism: sensitivity and specificity of ventilation-perfusion scintigraphy in PIOPED II study". Radiology 2008;246:941-946.

    CrossrefMedlineGoogle Scholar

  • 109. Tremblay E., Therasse E., Thomassin-Naggara I., Trop I. "Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation". Radiographics 2012;32:897-911.

    CrossrefMedlineGoogle Scholar

  • 110. Barritt D.W., Jordan S.C. "Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial". Lancet 1960;1:1309-1312.

    CrossrefMedlineGoogle Scholar

  • 111. Villasanta U. "Thromboembolic disease in pregnancy". Am J Obstet Gynecol 1965;93:142-160.

    CrossrefMedlineGoogle Scholar

  • 112. Erkens P.M., Prins M.H. "Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism". Cochrane Database Syst Rev 2010;9:CD001100.

    Google Scholar

  • 113. Mclintock C., Brighton T., Chunilal S., et al. "Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period". Aust N Z J Obstet Gynaecol 2012;52:14-22.

    CrossrefMedlineGoogle Scholar

  • 114. Rodie V.A., Thomson A.J., Stewart F.M., Quinn A.J., Walker I.D., Greer I.A. "Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series". BJOG 2002;109:1020-1024.

    CrossrefMedlineGoogle Scholar

  • 115. Bhutia S., Wong P.F. "Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism". Cochrane Database Syst Rev 2013;7:CD003074.

    Google Scholar

  • 116. Knight M., UKOSS "Antenatal pulmonary embolism: risk factors, management and outcomes". BJOG 2008;115:453-461.

    CrossrefMedlineGoogle Scholar

  • 117. Voke J., Keidan J., Pavord S., Spencer N.H., Hunt B.J. "British Society for Haematology Obstetric Haematology Group. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey". Br J Haematol 2007;139:545-558.

    CrossrefMedlineGoogle Scholar

  • 118. Friedrich E., Hameed A.B. "Fluctuations in anti-factor Xa levels with therapeutic enoxaparin anticoagulation in pregnancy". J Perinatol 2010;30:253-257.

    CrossrefMedlineGoogle Scholar

  • 119. Mcdonnell B.P., Glennon K., Mctiernan A., et al. "Adjustment of therapeutic LMWH to achieve specific target anti-fxa activity does not affect outcomes in pregnant patients with venous thromboembolism". J Thromb Thrombolysis 2017;43:105-111.

    CrossrefMedlineGoogle Scholar

  • 120. Boban A., Paulus S., Lambert C., Hermans C. "The value and impact of anti-Xa activity monitoring for prophylactic dose adjustment of low-molecular-weight heparin during pregnancy: a retrospective study". Blood Coagul Fibrinolysis 2017;28:199-204.

    CrossrefMedlineGoogle Scholar

  • 121. Fox N.S., Laughon S.K., Bender S.D., Saltzman D.H., Rebarber A. "Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis". Obstet Gynecol 2008;112:884-889.

    CrossrefMedlineGoogle Scholar

  • 122. Richter C., Sitzmann J., Lang P., Weitzel H., Huch A., Huch R. "Excretion of low molecular weight heparin in human milk". Br J Clin Pharmacol 2001;52:708-710.

    CrossrefMedlineGoogle Scholar

  • 123. Gilman A., Goodman L. "Anticoagulant, antithrombotic and thrombolytic drugs". The Pharmacologic Basis of Therapeutics 6th edition. New York, New York: Macmillan Publishing Company, 1980. 1347-1366.

    Google Scholar

  • 124. Vetter A., Perera G., Leithner K., Klima G., Bernkop-Schnurch A. "Development and in vivo bioavailability study of an oral fondaparinux delivery system". Eur J Pharm Sci 2010;41:489-497.

    CrossrefMedlineGoogle Scholar

  • 125. Wiesen M.H., Blaich C., Muller C., Streichert T., Pfister R., Michels G. "The direct factor Xa inhibitor rivaroxaban passes into human breast milk". Chest 2016;150:e1-e4.

    CrossrefMedlineGoogle Scholar

  • 126. Burnett A.E., Mahan C.E., Vazquez S.R., Oertel L.B., Garcia D.A., Ansell J. "Guidance for the practical management of the direct oral anticoagulants (doacs) in VTE treatment". J Thromb Thrombolysis 2016;41:206-232.

    CrossrefMedlineGoogle Scholar

  • 127. Shaw P., Duncan A., Vouyouka A., Ozsvath K. "Radiation exposure and pregnancy". J Vasc Surg 2011;53:28S-34S.

    CrossrefMedlineGoogle Scholar

  • 128. Corriere M.A., Passman M.A., Guzman R.J., Dattilo J.B., Naslund T.C. "Retrieving “nonretrievable” inferior vena caval Greenfield filters: a therapeutic option for filter malpositioning". Ann Vasc Surg 2004;18:629-634.

    CrossrefMedlineGoogle Scholar

  • 129. Harris S.A., Velineni R., Davies A.H. "Inferior vena cava filters in pregnancy: a systematic review". J Vasc Interv Radiol 2016;27:354-60e8.

    CrossrefMedlineGoogle Scholar

  • 130. Duffett L., Carrier M. "Inferior vena cava filters". J Thromb Haemost 2017;15:3-12.

    CrossrefMedlineGoogle Scholar

  • 131. Gupta S., Ettles D.F., Robinson G.J., Lindow S.W. "Inferior vena cava filter use in pregnancy: preliminary experience". BJOG 2008;115:785-788.

    CrossrefMedlineGoogle Scholar

  • 132. Kawamata K., Chiba Y., Tanaka R., Higashi M., Nishigami K. "Experience of temporary inferior vena cava filters inserted in the perinatal period to prevent pulmonary embolism in pregnant women with deep vein thrombosis". J Vasc Surg 2005;41:652-656.

    CrossrefMedlineGoogle Scholar

  • 133. Ganguli S., Tham J.C., Komlos F., Rabkin D.J. "Fracture and migration of a suprarenal inferior vena cava filter in a pregnant patient". J Vasc Interv Radiol 2006;17:1707-1711.

    CrossrefMedlineGoogle Scholar

  • 134. Mcconville R.M., Kennedy P.T., Collins A.J., Ellis P.K. "Failed retrieval of an inferior vena cava filter during pregnancy because of filter tilt: report of two cases". Cardiovasc Intervent Radiol 2009;32:174-177.

    CrossrefMedlineGoogle Scholar

  • 135. Cheung M.C., Asch M.R., Gandhi S., Kingdom J.C. "Temporary inferior vena caval filter use in pregnancy". J Thromb Haemost 2005;3:1096-1097.

    CrossrefMedlineGoogle Scholar

  • 136. Milford W., Chadha Y., Lust K. "Use of a retrievable inferior vena cava filter in term pregnancy: case report and review of literature". Aust N Z J Obstet Gynaecol 2009;49:331-333.

    CrossrefMedlineGoogle Scholar

  • 137. Jaff M.R., Mcmurtry M.S., Archer S.L., et al. "Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association". Circulation 2011;123:1788-1830.

    CrossrefMedlineGoogle Scholar

  • 138. Bloom A.I., Farkas A., Kalish Y., Elchalal U., Spectre G. "Pharmacomechanical catheter-directed thrombolysis for pregnancy-related iliofemoral deep vein thrombosis". J Vasc Interv Radiol 2015;26:992-1000.

    CrossrefMedlineGoogle Scholar

  • 139. Herrera S., Comerota A.J., Thakur S., et al. "Managing iliofemoral deep venous thrombosis of pregnancy with a strategy of thrombus removal is safe and avoids post-thrombotic morbidity". J Vasc Surg 2014;59:456-464.

    CrossrefMedlineGoogle Scholar

  • 140. Meththananda A.T.M.H., Anwar M., Davies A.H. "PPM.85 Radiation considerations for catheter directed thrombolysis in iliofemoral thrombosis in pregnancy". Arch Dis Child Fetal Neonatal 2014;99:A149.

    CrossrefGoogle Scholar

  • 141. Piazza G., Hohlfelder B., Jaff M.R., et al. "A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II Study". J Am Coll Cardiol Intv 2015;8:1382-1392.

    View ArticleGoogle Scholar

  • 142. Kucher N., Boekstegers P., Muller O.J., et al. "Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism". Circulation 2014;129:479-486.

    CrossrefMedlineGoogle Scholar

  • 143. Schissler A.J., Gylnn R.J., Sobieszczyk P.S., Waxman A.B. "Ultrasound-assisted catheter-directed thrombolysis compared with anticoagulation alone for treatment of intermediate-risk pulmonary embolism". Pulm Circ 2018;8:2045894018800265.

    CrossrefMedlineGoogle Scholar

  • 144. Krishnamurthy P., Martin C.B., Kay H.H., et al. "Catheter-directed thrombolysis for thromboembolic disease during pregnancy: a viable option". J Matern Fetal Med 1999;8:24-27.

    MedlineGoogle Scholar

  • 145. Pick J., Berlin D., Horowitz J., Winokur R., Sista A.K., Lichtman A.D. "Massive pulmonary embolism in pregnancy treated with catheter-directed tissue plasminogen activator". A A Case Rep 2015;4:91-94.

    CrossrefMedlineGoogle Scholar

  • 146. Bell W.R. "Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics". Rev Cardiovasc Med 2002;3:Suppl 2: S34-S44.

    MedlineGoogle Scholar

  • 147. Marti C., John G., Konstantinides S., et al. "Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis". Eur Heart J 2015;36:605-614.

    CrossrefMedlineGoogle Scholar

  • 148. Te Raa G.D., Ribbert L.S., Snijder R.J., Biesma D.H. "Treatment options in massive pulmonary embolism during pregnancy; a case-report and review of literature". Thromb Res 2009;124:1-5.

    CrossrefMedlineGoogle Scholar

  • 149. Capstick T., Henry M.T. "Efficacy of thrombolytic agents in the treatment of pulmonary embolism". Eur Respir J 2005;26:864-874.

    CrossrefMedlineGoogle Scholar

  • 150. Martillotti G., Boehlen F., Robert-Ebadi H., Jastrow N., Righini M., Blondon M. "Treatment options for severe pulmonary embolism during pregnancy and the postpartum period: a systematic review". J Thromb Haemost 2017;15:1942-1950.

    CrossrefMedlineGoogle Scholar

  • 151. Sharma N.S., Wille K.M., Bellot S.C., Diaz-Guzman E. "Modern use of extracorporeal life support in pregnancy and postpartum". ASAIO J 2015;61:110-114.

    CrossrefMedlineGoogle Scholar

  • 152. Bataillard A., Hebrard A., Gaide-Chevronnay L., et al. "Extracorporeal life support for massive pulmonary embolism during pregnancy". Perfusion 2016;31:169-171.

    CrossrefMedlineGoogle Scholar